The sold production of basic pharmaceutical products in Belgium is forecasted to increase from 25.3 million kilograms in 2024 to 31.518 million kilograms in 2028. This presents a steady year-on-year growth ranging between 6.2% to 6.8%, with a compound annual growth rate (CAGR) of approximately 5.6% over the five-year period from 2024 to 2028. In 2023, the actual production stood at 24 million kilograms, reflecting a healthy upward trend.
Future trends to watch for:
• Increasing investments in pharmaceutical R&D.• Adoption of advanced manufacturing technologies.• Growing demand due to an aging population and global health challenges.• Regulatory changes and their impact on production capacities and methodologies.• Potential supply chain disruptions or shifts due to geopolitical factors.
